Literature DB >> 1926241

Cholinergic deafferentation after focal cerebral infarct in rats.

K Kataoka1, T Hayakawa, R Kuroda, T Yuguchi, K Yamada.   

Abstract

BACKGROUND AND
PURPOSE: For a better understanding of neuronal network disturbances after stroke, we investigated the changes in the cholinergic system after experimental focal infarct.
METHODS: We quantitatively evaluated the highly sensitive acetylcholinesterase histochemistry and local glucose utilization 7 days after left middle cerebral artery occlusion in Wistar rats.
RESULTS: In all rats with occlusion, the ipsilateral frontal cortex and the nucleus basalis Meynert developed no infarct, whereas the subcortical striatum did. In the frontal cortex on the occlusion side, the acetylcholinesterase-positive fiber density was significantly (p less than 0.05) reduced; a computer-assisted image-analyzing system quantified approximately 1.0 m/mm3 brain cortex acetylcholinesterase-positive fibers in the ipsilateral frontal cortex layers II-IV and approximately 9.7 m/mm3 brain cortex acetylcholinesterase-positive fibers in the contralateral frontal cortex layers II-IV. Local glucose utilization was also significantly (p less than 0.05) decreased in the ipsilateral frontal cortex compared to the contralateral side and sham-operated animals.
CONCLUSIONS: These results suggest that functional disturbances and disruption of the cholinergic pathway between the frontal cortex and the nucleus basalis Meynert occur after middle cerebral artery occlusion in rats.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1926241     DOI: 10.1161/01.str.22.10.1291

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Mapping neuronal density in peri-infarct cortex with PET.

Authors:  Jean-Claude Baron
Journal:  Hum Brain Mapp       Date:  2017-07-21       Impact factor: 5.038

2.  Watermaze performance after middle cerebral artery occlusion in the rat: the role of sensorimotor versus memory impairments.

Authors:  Deborah Bingham; Stephen J Martin; I Mhairi Macrae; Hilary V O Carswell
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-29       Impact factor: 6.200

3.  Temporal remodeling of pial collaterals and functional deficits in a murine model of ischemic stroke.

Authors:  Benjamin Okyere; Miranda Creasey; Yeonwoo Lebovitz; Michelle H Theus
Journal:  J Neurosci Methods       Date:  2017-09-18       Impact factor: 2.390

4.  Severe Lesions Involving Cortical Cholinergic Pathways Predict Poorer Functional Outcome in Acute Ischemic Stroke.

Authors:  Jian-Feng Qu; Yang-Kun Chen; Gen-Pei Luo; Jiang-Hao Zhao; Huo-Hua Zhong; Han-Peng Yin
Journal:  Stroke       Date:  2018-12       Impact factor: 7.914

5.  Sex-Dependent Differences in Physical Exercise-Mediated Cognitive Recovery Following Middle Cerebral Artery Occlusion in Aged Rats.

Authors:  Charles H Cohan; Mehdi Youbi; Isabel Saul; Alex A Ruiz; Concepcion C Furones; Pujan Patel; Edwin Perez; Ami P Raval; Kunjan R Dave; Weizhao Zhao; Chuanhui Dong; Tatjana Rundek; Sebastian Koch; Ralph L Sacco; Miguel A Perez-Pinzon
Journal:  Front Aging Neurosci       Date:  2019-09-18       Impact factor: 5.750

6.  Cholinergic and hippocampal systems facilitate cross-domain cognitive recovery after stroke.

Authors:  Michael J O'Sullivan; Lena K L Oestreich; Paul Wright; Andrew N Clarkson
Journal:  Brain       Date:  2022-06-03       Impact factor: 15.255

7.  Citicoline Treatment in Acute Ischemic Stroke: A Randomized, Single-Blind TMS Study.

Authors:  Enrico Premi; Valentina Cantoni; Alberto Benussi; Nicola Gilberti; Veronica Vergani; Ilenia Delrio; Massimo Gamba; Raffaella Spezi; Angelo Costa; Alessandro Padovani; Barbara Borroni; Mauro Magoni
Journal:  Front Neurol       Date:  2022-07-13       Impact factor: 4.086

8.  The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice.

Authors:  Ping-Chia Li; Li-Fen Liu; Ming-Jia Jou; Hao-Kuang Wang
Journal:  BMC Neurosci       Date:  2016-06-13       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.